EUVIMEDEUVIMED entdecken
Crossref

Thyroid Diseases in Patients With Pituitary Neuroendocrine Tumours

Nan Fengjuan, Mu Chengzhi, Yu Shengyuan

Clinical Endocrinology · 2025

DOI: 10.1111/cen.15256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Nan Fengjuan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology Ultrasound, Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pituitary Neoplasms, Thyroid Diseases. Die Arbeit nennt 24 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Due to the hypothalamic–pituitary–thyroid axis, thyroid disease is often associated with pituitary neuroendocrine tumours (PitNETs). However, the associations across different PitNETs subtypes remain underexplored. This study investigates the characteristics of thyroid disease in patients with different PitNETs subtypes and evaluates the impact of PitNETs treatment on thyroid disease.

Methods

A retrospective analysis was conducted on 168 patients with PitNETs who were categorised into 3 groups: GH ( n = 53), PRL ( n = 65) and NF ( n = 50). All patients underwent thyroid ultrasonography, pituitary tests and thyroid function tests before treatment and 1 year after treatment.

Results

Thyroid volume was significantly larger in the GH group (30.78 ± 7.87 mL, p < 0.01). The incidence of thyroid goitre and nodules was markedly higher in the GH group (73.58%, p < 0.01; 54.17%, p < 0.01), with a significantly higher proportion of multiple thyroid nodules in the GH group (79.31%, p < 0.01). Autoimmune thyroiditis was more common in PRL group (18.46%, p = 0.04), associated with elevated TPOAb (169.63 ± 325.28 IU/mL, p = 0.02) and TGAb antibody levels (236.23 ± 379.91 IU/mL, p = 0.02). One‐year postoperative follow‐up, the postoperative thyroid volume decreased from 23.45 ± 8.99 mL to 20.42 ± 6.48 mL ( p < 0.01). The incidence of thyroid goiter decreased from 36.90% to 13.10% ( p < 0.01). In patients with autoimmune thyroiditis, TPOAb and TGAb levels decreased significantly after treatment ( p = 0.01, p < 0.01, respectively).

Conclusion

Increased thyroid volume, goiter and multiple nodules are prevalent in GH‐PitNETs patients, while autoimmune thyroiditis predominates in PRL‐PitNETs. Treatment of PitNETs alleviates these thyroid manifestations. Routine thyroid ultrasound monitoring is recommended for PitNETs patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsPituitary NeoplasmsThyroid DiseasesHumansFemaleMaleRetrospective StudiesMiddle AgedAdultAgedThyroid GlandThyroid Function Tests

Stichwörter der Autor:innen

growth hormonepituitary neuroendocrine tumoursprolactinthyroid diseasethyroid ultrasonography

Autor:innen und Institutionen

  • Department of Gynecology Ultrasound, Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Fengjuan, N., Chengzhi, M., & Shengyuan, Y. (2025). Thyroid Diseases in Patients With Pituitary Neuroendocrine Tumours. Clinical Endocrinology. https://doi.org/10.1111/cen.15256

Vancouver

Fengjuan N, Chengzhi M, Shengyuan Y. Thyroid Diseases in Patients With Pituitary Neuroendocrine Tumours. Clinical Endocrinology. 2025. doi:10.1111/cen.15256

BibTeX
@article{Fengjuan2025,
  author = {Fengjuan, Nan and Chengzhi, Mu and Shengyuan, Yu},
  title = {Thyroid Diseases in Patients With Pituitary Neuroendocrine Tumours},
  journal = {Clinical Endocrinology},
  year = {2025},
  doi = {10.1111/cen.15256}
}
Kostenlos starten →